Large gap with delayed quotes
|
Last quote
01/06/2025 -
17:31:17
|
Bid
01/06/2025 -
17:19:07
|
Bid Volume |
Ask
01/06/2025 -
20:44:48
|
Ask Volume |
|---|---|---|---|---|
|
29.00
-0.25
(
-0.85% )
|
28.95
|
271 |
29.90
|
189 |
Analysis date: 03.01.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.09.2024.
Interest
Very strong
Very strong
Very strong interest since 03.01.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 20.12.2024 at a price of 28.75.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Positive
Positive
The forty day Medium Term Technical Trend is positive since 03.01.2025. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 28.166.
4wk Rel Perf
4.96%
4.96%
The four week relative overperformance versus STOXX600 is 4.96%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 12.03.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.60%.
Mkt Cap in $bn
1.06
1.06
With a market capitalization <$2bn, POLYPEPTIDE GROUP AG is considered a small-cap stock.
G/PE Ratio
3.48
3.48
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
31.08
31.08
The estimated PE is for the year 2026.
LT Growth
108.23%
108.23%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The twelve month estimated dividend yield represents 0.12% of earnings forecasts.
Beta
165
165
For 1% of index variation, the stock varies on average by 1.65%.
Correlation
0.33
0.33
Stock movements are strongly independent of index variations.
Value at Risk
7.02
7.02
The value at risk is estimated at CHF 7.02. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
20.08.2021
20.08.2021